Regression of a basal cell carcinoma infiltrating the brain after vismodegib therapy

J Dtsch Dermatol Ges. 2014 Oct;12(10):906-7. doi: 10.1111/ddg.12342. Epub 2014 Jul 17.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Anilides / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Brain / pathology*
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / pathology*
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / pathology*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Neoplasm Invasiveness
  • Pyridines / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology*
  • Treatment Outcome

Substances

  • Anilides
  • Antineoplastic Agents
  • HhAntag691
  • Pyridines